BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29522175)

  • 1. Rare Variant, Gene-Based Association Study of Hereditary Melanoma Using Whole-Exome Sequencing.
    Artomov M; Stratigos AJ; Kim I; Kumar R; Lauss M; Reddy BY; Miao B; Daniela Robles-Espinoza C; Sankar A; Njauw CN; Shannon K; Gragoudas ES; Marie Lane A; Iyer V; Newton-Bishop JA; Timothy Bishop D; Holland EA; Mann GJ; Singh T; Daly MJ; Tsao H
    J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 29522175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families.
    Njauw CN; Kim I; Piris A; Gabree M; Taylor M; Lane AM; DeAngelis MM; Gragoudas E; Duncan LM; Tsao H
    PLoS One; 2012; 7(4):e35295. PubMed ID: 22545102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Variants and Somatic Alterations Associated with MITF-E318K Germline Mutation in Melanoma Patients.
    Vergani E; Frigerio S; Dugo M; Devecchi A; Feltrin E; De Cecco L; Vallacchi V; Cossa M; Di Guardo L; Manoukian S; Peissel B; Ferrari A; Gallino G; Maurichi A; Rivoltini L; Sensi M; Rodolfo M
    Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma.
    Betti M; Aspesi A; Biasi A; Casalone E; Ferrante D; Ogliara P; Gironi LC; Giorgione R; Farinelli P; Grosso F; Libener R; Rosato S; Turchetti D; Maffè A; Casadio C; Ascoli V; Dianzani C; Colombo E; Piccolini E; Pavesi M; Miccoli S; Mirabelli D; Bracco C; Righi L; Boldorini R; Papotti M; Matullo G; Magnani C; Pasini B; Dianzani I
    Cancer Lett; 2016 Aug; 378(2):120-30. PubMed ID: 27181379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare germline variants in known melanoma susceptibility genes in familial melanoma.
    Goldstein AM; Xiao Y; Sampson J; Zhu B; Rotunno M; Bennett H; Wen Y; Jones K; Vogt A; Burdette L; Luo W; Zhu B; Yeager M; Hicks B; Han J; De Vivo I; Koutros S; Andreotti G; Beane-Freeman L; Purdue M; Freedman ND; Chanock SJ; Tucker MA; Yang XR
    Hum Mol Genet; 2017 Dec; 26(24):4886-4895. PubMed ID: 29036293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Family-based whole-exome sequencing identifies rare variants potentially related to cutaneous melanoma predisposition in Brazilian melanoma-prone families.
    Fidalgo F; Torrezan GT; Sá BCS; Barros BDF; Moredo LF; Valieris R; de Souza SJ; Duprat JP; Krepischi ACV; Carraro DM
    PLoS One; 2022; 17(1):e0262419. PubMed ID: 35085295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated case-control and somatic-germline interaction analyses of melanoma susceptibility genes.
    Yu Y; Hu H; Chen JS; Hu F; Fowler J; Scheet P; Zhao H; Huff CD
    Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt B):2247-2254. PubMed ID: 29317335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. POLE mutations in families predisposed to cutaneous melanoma.
    Aoude LG; Heitzer E; Johansson P; Gartside M; Wadt K; Pritchard AL; Palmer JM; Symmons J; Gerdes AM; Montgomery GW; Martin NG; Tomlinson I; Kearsey S; Hayward NK
    Fam Cancer; 2015 Dec; 14(4):621-8. PubMed ID: 26251183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma.
    Johansson PA; Nathan V; Bourke LM; Palmer JM; Zhang T; Symmons J; Howlie M; Patch AM; Read J; Holland EA; Schmid H; Warrier S; Glasson W; Höiom V; Wadt K; Jönsson G; Olsson H; Ingvar C; Mann G; Brown KM; Hayward NK; Pritchard AL
    Melanoma Res; 2019 Oct; 29(5):483-490. PubMed ID: 31464824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers.
    Pritchard AL; Johansson PA; Nathan V; Howlie M; Symmons J; Palmer JM; Hayward NK
    PLoS One; 2018; 13(4):e0194098. PubMed ID: 29641532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole Exome Sequencing Identifies Candidate Genes Associated with Hereditary Predisposition to Uveal Melanoma.
    Abdel-Rahman MH; Sample KM; Pilarski R; Walsh T; Grosel T; Kinnamon D; Boru G; Massengill JB; Schoenfield L; Kelly B; Gordon D; Johansson P; DeBenedictis MJ; Singh A; Casadei S; Davidorf FH; White P; Stacey AW; Scarth J; Fewings E; Tischkowitz M; King MC; Hayward NK; Cebulla CM
    Ophthalmology; 2020 May; 127(5):668-678. PubMed ID: 32081490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
    Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
    Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors-A Cohort Study.
    Aswath K; Welch J; Gubbi S; Veeraraghavan P; Avadhanula S; Gara SK; Dikoglu E; Merino M; Raffeld M; Xi L; Kebebew E; Klubo-Gwiezdzinska J
    Front Endocrinol (Lausanne); 2021; 12():653401. PubMed ID: 34326811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer risks associated with the germline MITF(E318K) variant.
    Guhan SM; Artomov M; McCormick S; Njauw C-; Stratigos AJ; Shannon K; Ellisen LW; Tsao H
    Sci Rep; 2020 Oct; 10(1):17051. PubMed ID: 33051548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel germline variant in the DOT1L gene co-segregating in a Dutch family with a history of melanoma.
    Salgado C; Kwesi-Maliepaard EM; Jochemsen AG; Visser M; Harland M; van Leeuwen F; van Doorn R; Gruis N
    Melanoma Res; 2019 Dec; 29(6):582-589. PubMed ID: 31524790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional Common and Rare
    Bao R; Ng A; Sasaki M; Esai Selvan M; Katti A; Lee H; Huang L; Skol AD; Lavarino C; Salvador H; Klein RJ; Gümüş ZH; Mora J; Onel K
    Cancer Prev Res (Phila); 2021 Apr; 14(4):441-454. PubMed ID: 33419763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis.
    Chatterjee A; Stockwell PA; Ahn A; Rodger EJ; Leichter AL; Eccles MR
    Oncotarget; 2017 Jan; 8(4):6085-6101. PubMed ID: 28030832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new POT1 germline mutation-expanding the spectrum of POT1-associated cancers.
    Wilson TL; Hattangady N; Lerario AM; Williams C; Koeppe E; Quinonez S; Osborne J; Cha KB; Else T
    Fam Cancer; 2017 Oct; 16(4):561-566. PubMed ID: 28389767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1-associated protein (BAP1)-inactivated melanocytic tumors.
    Zhang AJ; Rush PS; Tsao H; Duncan LM
    J Cutan Pathol; 2019 Dec; 46(12):965-972. PubMed ID: 31233225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Throughput Sequencing Identifies 3 Novel Susceptibility Genes for Hereditary Melanoma.
    Campos C; Fragoso S; Luís R; Pinto F; Brito C; Esteves S; Pataco M; Santos S; Machado P; Vicente JB; Rosa JC; Cavaco BM; Moura C; Pojo M
    Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32276436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.